Flatiron Health Extends NCCN Collaboration Through 2028, Expands…

Event summary

Flatiron Health renewed its collaboration with NCCN through 2028, extending a partnership that began in 2014.
The agreement expands access to Flatiron Telescope, an AI-powered oncology intelligence platform, for NCCN Member Institutions.
Participating NCCN Member Institutions will continue to receive curated, de-identified oncology datasets spanning over 6M+ patients.
Flatiron will award up to seven research grants biannually through the Flatiron Grants program.

The big picture

The renewal of Flatiron Health's collaboration with NCCN underscores the growing importance of real-world data and AI-powered tools in advancing oncology research. This partnership aligns with broader industry trends toward data-driven healthcare solutions and the increasing need for high-quality, accessible cancer care. The scale of the collaboration, involving over 6M+ patient datasets and multiple research grants, positions Flatiron Health as a key player in the oncology data ecosystem.

What we're watching

Data Utilization: How the expanded access to Flatiron Telescope will accelerate research and insights across NCCN Member Institutions.
Research Impact: Whether the renewed collaboration will lead to significant advancements in oncology care and treatment.
Market Positioning: The pace at which Flatiron Health can leverage this partnership to strengthen its position in the oncology data and analytics space.